PERRONE, Francesca
 Distribuzione geografica
Continente #
EU - Europa 128
AS - Asia 112
NA - Nord America 87
SA - Sud America 10
AF - Africa 8
Totale 345
Nazione #
US - Stati Uniti d'America 82
SG - Singapore 40
HK - Hong Kong 37
DE - Germania 26
IE - Irlanda 25
CN - Cina 15
IT - Italia 15
RU - Federazione Russa 12
SE - Svezia 12
BR - Brasile 9
VN - Vietnam 7
BJ - Benin 6
GB - Regno Unito 6
KR - Corea 6
FI - Finlandia 5
FR - Francia 5
CA - Canada 4
ES - Italia 4
PL - Polonia 4
NL - Olanda 3
AT - Austria 2
IR - Iran 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IN - India 1
LT - Lituania 1
MX - Messico 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 345
Città #
Hong Kong 37
Dublin 25
Ashburn 16
Munich 14
Singapore 11
Novara 10
Beijing 9
Cotonou 6
Seoul 6
Los Angeles 5
Frankfurt am Main 4
Moscow 4
Warsaw 4
Amsterdam 3
Ho Chi Minh City 3
London 3
Turku 3
Bremen 2
Brooklyn 2
Buffalo 2
Chandler 2
Dallas 2
Denver 2
Helsinki 2
Lawrence 2
Nuremberg 2
Princeton 2
San Mateo 2
São Paulo 2
Toronto 2
West Jordan 2
Aberdeen 1
Andover 1
Ardabil 1
Atlanta 1
Boardman 1
Bocaiúva 1
Brno 1
Brussels 1
Cagliari 1
Can Tho 1
Charlotte 1
Chennai 1
Curitiba 1
Dhaka 1
Florence 1
Haiphong 1
Jacksonville 1
Jakarta 1
Johannesburg 1
Las Vegas 1
Lima 1
Lisbon 1
Manaus 1
Maricá 1
Miami 1
Monmouth Junction 1
New York 1
Norwalk 1
Ottawa 1
Piteşti 1
Pompéu 1
Poplar 1
Rio de Janeiro 1
Roubaix 1
San Francisco 1
Seattle 1
Secaucus 1
Sousse 1
Stockholm 1
Strasbourg 1
Tashkent 1
Teixeira de Freitas 1
The Dalles 1
Thái Bình 1
Tianjin 1
Trumbull 1
Tuxtla Gutiérrez 1
Wilmington 1
Zanjan 1
Totale 240
Nome #
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors 80
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy 73
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: A protocol 47
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients 44
The association of financial difficulties with clinical outcomes in cancer patients: Secondary analysis of 16 academic prospective clinical trials conducted in Italy 41
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system 39
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study 30
Totale 354
Categoria #
all - tutte 2.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 1 0
2021/202222 3 1 2 3 3 0 1 0 1 2 2 4
2022/202337 5 1 2 0 2 3 1 0 19 1 1 2
2023/202457 1 1 6 0 5 2 24 2 0 2 7 7
2024/2025107 1 1 4 0 0 9 4 29 18 7 4 30
2025/2026129 21 15 15 37 40 1 0 0 0 0 0 0
Totale 354